● BreakingLaws · federal-scheduling

DEA Asks Judge to Reject Motion to Reopen Rescheduling Hearing

The agency wants the presiding judge to deny a bid for new testimony and discovery, a request that could add months to the Schedule III timeline.

By Ethan Walsh, Investigations EditorPublished October 22, 20265 min read
A view of the Russian White House, a prominent government building in Moscow, Russia.

A view of the Russian White House, a prominent government building in Moscow, Russia.

The Drug Enforcement Administration asked the judge overseeing marijuana rescheduling to reject a motion to reopen the hearing for new testimony and discovery, Cannabis Business Times reported Oct. 22. A reopened record could delay Schedule III and the 280E tax relief that depends on it.

The DEA wants the hearing record closed, and it said so in a filing opposing a motion to reopen it. What we know is narrow.

According to Cannabis Business Times, the DEA urged the judge to deny an anti-rescheduling motion seeking new testimony and discovery. The outlet's headline describes the motion as "prohibitionist bait" and says the agency wants the process wrapped up.

That's the entire public signal. The report, as summarized in the feed we reviewed, doesn't give a docket number, the filing date, or the name of the party that moved to reopen, and it doesn't say whether the judge has set a briefing schedule or a ruling date.

We aren't going to fill those gaps with guesses. Here's what the filing's existence does establish:

  • A party opposed to moving marijuana out of Schedule I has asked to reopen a hearing record.
  • The DEA, the agency that proposed the rescheduling, opposes that request.
  • The dispute sits before a presiding judge, not the DEA Administrator, so the first ruling will be procedural.

The DEA arguing for finality in its own rulemaking is notable. This process has run more than two years since the agency published its proposed rule in May 2024.

A motion to reopen is a timing tool as much as a legal one, because every new witness and document request resets the clock.

Rescheduling under the Controlled Substances Act isn't an ordinary notice-and-comment exercise. 21 U.S.C. 811 requires rulemaking on the record after an opportunity for a hearing. That's why an administrative judge, rather than a DEA policy office, is managing the evidence.

On-the-record proceedings have rules about when evidence closes, and a party that wants to reopen has to persuade the judge that something material has changed or that the existing record is deficient. Otherwise the record stays shut.

Discovery is the sharper edge. Opening it invites document demands on the DEA and on the Department of Health and Human Services, whose scientific review underpins the Schedule III proposal. Depositions and subpoena fights can take months to resolve. Cutting a hearing's finish line off is hard. Moving it back is easy.

In paraphrase, the DEA's position is that the proceeding should end rather than expand, and that the motion to reopen is an attempt to relitigate a question the record has already answered.

That characterization comes from the framing of the trade report, not from a quoted passage of the filing itself. We haven't seen the filing text. Until we do, treat the DEA's legal arguments as unconfirmed.

The money at stake is the 280E deduction bar, which Schedule III would lift for plant-touching operators.

Internal Revenue Code Section 280E denies business deductions to anyone trafficking in Schedule I or II substances. Marijuana sits in Schedule I. Move it to Schedule III and the statutory hook for 280E goes away.

For multistate operators, that's the financial prize. Effective tax rates in the licensed industry have long run far above those of comparable retailers or manufacturers, and cash taxes are a recurring line in MSO earnings calls. A delay of even one quarter pushes back relief that operators have been modeling into their balance sheets.

Rescheduling wouldn't make the market federally legal. It wouldn't touch state licensing in California, Ohio or anywhere else, and it wouldn't by itself open interstate commerce. But it would change the tax math on day one, and that's why a procedural motion matters to people who have never read an ALJ order.

The math is simple. Every month of delay is a month of 280E.

The next documents to pull are the motion itself, any opposition brief, and the judge's scheduling order.

Our standard approach with a thin signal is to work from the docket. For this one, the useful record would include:

  1. The motion to reopen. It should identify the movant, the specific testimony sought, and the legal standard invoked.
  2. The DEA's opposition. It should show whether the agency argued untimeliness, lack of materiality, or prejudice from delay.
  3. Any scheduling order. A short briefing window would signal that the judge wants to rule quickly.
  4. Replies or joinders. If other parties pile onto the motion, the delay risk rises sharply.

One question should anchor the reading. Is the movant seeking evidence that postdates the original record, or revisiting evidence that was available and not pursued? The first is a stronger argument for reopening. The second is the usual ground for denial.

For full background on this story, see the CannIntel topic hub on DEA rescheduling, where we're tracking each filing and ruling as it appears.

The next signal is the judge's ruling on the motion. A denial keeps the record closed and moves the proceeding toward a recommended decision, while a grant of even limited discovery would make a quiet 2026 finish hard to believe.

Full context

For complete background, history, and our ongoing coverage of this story:

Open the CannIntel topic hub →

Sources

DEA reschedulingSchedule III280Eadministrative hearingfederal cannabis policy
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Laws

More from the newsroom